How many studies have been conducted on Soybean Trypsin Inhibitor?

BiohacksAI has indexed 210 PubMed studies on Soybean Trypsin Inhibitor, including 1 randomized controlled trials (RCTs). 1% of studies involve human subjects.

What are the main research areas for Soybean Trypsin Inhibitor?

The primary research domains for Soybean Trypsin Inhibitor are 🧠 Focus & Attention, 🦠 Gut & Microbiome, 🏋️ Muscle & Hypertrophy. This is based on analysis of 210 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Soybean Trypsin Inhibitor

A high-molecular-weight protein (approximately 22,500) containing 198 amino acid residues. It is a strong inhibitor of trypsin and human plasmin.

210+ PubMed studies analyzed · 1 RCTs · Evidence Score: 42.9

Research Domains

Soybean Trypsin Inhibitor has been studied across 16 research domains including 🧠 Focus & Attention, 🦠 Gut & Microbiome, 🏋️ Muscle & Hypertrophy, 🔬 Oncology, 🌤️ Mood & Depression. The primary research focus is 🧠 Focus & Attention with 20% of studies addressing this area.

Loading evidence profile...

This evidence profile for Soybean Trypsin Inhibitor is generated deterministically from 210 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.